Here's A Swift Strategy To Make It Along With LY2109761

We also assessed whether the time between diagnosis and RP was associated with any of the outcome variables and whether in the delayed RP group the PSA doubling time (PSADT) was associated with any outcomes, using univariate analyses in the 2 separate study groups. Third, we compared time to biochemical progression after RP between groups http://www.selleck.cn/products/Staurosporine.html using Kaplan-Meier, log-rank, and Breslow analysis (tests equality of survival functions by weighting all time points by the number of cases at risk at each time point), using both moment of diagnosis and moment of RP as t = 0, because the immediate RP group likely has a longer follow-up after RP to show biochemical progression, thus possibly introducing a bias. Then, we assessed whether study group was predictive for time to biochemical progression using Cox regression analysis, correcting for differences in variables at the moment of diagnosis as well as at the moment of RP. Finally, we analyzed whether time between diagnosis and RP was predictive for biochemical progression after RP in separate analyses for the immediate RP group and the delayed RP group. Parameters not further analyzed because of small number of events were mortality (3 men died in the delayed RP group, none of them because of prostate cancer) and seminal vesicle invasion (seen in 1 man in http://www.selleckchem.com/products/ly2109761.html the immediate RP group). Combining the data of different ERSPC study centers was considered, but rejected because of the small differences in screening protocols that would result in http://www.selleckchem.com/products/epz-5676.html heterogeneity in the study population. P values (2-sided)